ORL : what's new in 2024

This article highlights recent advancements in otorhinolaryngology. It reviews innovations in managing sudden sensory-neural hearing loss through low-dose glucocorticoid treatments and explores pediatric audiology breakthroughs, particularly gene therapy for DFNB9 deafness. In speech pathology and o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revue médicale suisse 2025-01, Vol.21 (902), p.147
Hauptverfasser: Anschuetz, Lukas, Fries, Sophie, Todic, Jelena, Glasson, Nicolas, Salati, Victoria, Gorostidi, François, Sandu, Kishore, Lambercy, Karma, Simon, Christian
Format: Artikel
Sprache:fre
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This article highlights recent advancements in otorhinolaryngology. It reviews innovations in managing sudden sensory-neural hearing loss through low-dose glucocorticoid treatments and explores pediatric audiology breakthroughs, particularly gene therapy for DFNB9 deafness. In speech pathology and oncology, a new minimally invasive robotic surgical approach enhances organ preservation for head and neck cancers. Rhinology advancements include biological therapies for chronic rhinosinusitis with polyps. Together, these developments expand therapeutic options, significantly improving patient quality of life in the ORL field.
ISSN:1660-9379
DOI:10.53738/REVMED.2025.21.902.147